aquavac vibrio oral
intervet intenational bv - vibrio anguillarumvibrio ordalii 60 % rps60 - oral emulsion - fish - vibrio vaccine
aquavac vibrio oral
intervet intenational bv - vibrio anguillarumvibrio ordalii 60 % rps60 - oral emulsion - fish - vibrio vaccine
aquavac vibrio oral
intervet intenational bv - vibrio anguillarumvibrio ordalii 60 % rps60 - oral emulsion - fish - vibrio vaccine
aquavac vibrio oral
intervet intenational bv - vibrio anguillarumvibrio ordalii 60 % rps60 - oral emulsion - fish - vibrio vaccine
anguillvac-c
the tasmanian salmonid growers association limited - vibrio anguillarum; formalin - topical solution/suspension - vibrio anguillarum ungrouped active 0.0 p; formalin ungrouped other 5.0 ml/l - immunotherapy - salmonids - vibrio anguillarum
aquavac vibrio immersion & injection
schering plough limited - listonella vibrio anguillarum serotype i strain 78-skid inactivated listonella vibrio anguillarum serotype ii alpha strain msc 275 inactivated - conc for dip and suspension for inj - 75 unknown - fish - (rainbow) trout - immunological - inactivated vaccine
vaxchora- cholera vaccine, live, oral kit
paxvax, inc. - vibrio cholerae cvd 103-hgr strain live antigen (unii: v9g528e9e0) (vibrio cholerae cvd 103-hgr strain live antigen - unii:v9g528e9e0) - vibrio cholerae cvd 103-hgr strain live antigen 1200000000 [cfu] - vaxchora is a vaccine indicated for active immunization against disease caused by vibrio cholerae serogroup o1 in adults 18 through 64 years of age traveling to cholera-affected areas. the effectiveness of vaxchora has not been established in persons living in cholera-affected areas. the effectiveness of vaxchora has not been established in persons who have pre-existing immunity due to previous exposure to v. cholerae or receipt of a cholera vaccine. vaxchora has not been shown to protect against disease caused by v. cholerae serogroup o139 or other non-o1 serogroups. do not use in persons who have a history of severe allergic reaction (e.g., anaphylaxis) to any ingredient of vaxchora or to a previous dose of any cholera vaccine [see description (11)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to vaxchora during pregnancy. to enroll in or obtain information about the registry, please call paxvax at 1-800-533-5899. risk summary vaxch
websters vibrio vaccine for cattle
virbac (australia) pty ltd - campylobacter fetus venerealis type1 csiro straind.78/12; campylobacter fetus (vibro fetus) (refer aliases); thiomersal - parenteral liquid/solution/suspension - campylobacter fetus venerealis type1 csiro straind.78/12 vaccine-microbial active 0.0 p; campylobacter fetus (vibro fetus) (refer aliases) vaccine-microbial active 0.0 p; thiomersal mercury other 0.13 g/l - immunotherapy - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - bovine venereal campylobacteriosis (bvc) | vaccine | bovine vibriosis | equine rotavirus
apvma veterinary use permit 12623- anguimonas vaccine/ farm salmonids/ vibrio anguillarum and areomonas salmonicida
apvma permit - vaccine - vibrio anguillarum+vaccine - aeromonad - vaccine
dukoral oral inactivated cholera vaccine liquid vial and buffer powder sachet
seqirus pty ltd - vibrio cholerae, quantity: 31.25 billion organisms; vibrio cholerae, quantity: 1 mg - oral liquid, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate dihydrate; water for injections; monobasic sodium phosphate dihydrate - cholera caused by serogroup 01 vibrio cholerae: active immunisation of adults and children from two years of age, who will be visiting areas epidemic or endemic for cholera and who are at high risk of infection.